Global IBS-C Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global IBS-C Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for IBS-C Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for IBS-C Drugs by Country/Region, 2017, 2022 & 2028

2.2 IBS-C Drugs Segment by Type

2.2.1 Linaclotide

2.2.2 Lubiprostone

2.2.3 Osmotic Laxatives

2.2.4 Stimulant Laxatives

2.2.5 Others

2.3 IBS-C Drugs Sales by Type

2.3.1 Global IBS-C Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global IBS-C Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global IBS-C Drugs Sale Price by Type (2017-2022)

2.4 IBS-C Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 IBS-C Drugs Sales by Application

2.5.1 Global IBS-C Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global IBS-C Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global IBS-C Drugs Sale Price by Application (2017-2022)

3 Global IBS-C Drugs by Company

3.1 Global IBS-C Drugs Breakdown Data by Company

3.1.1 Global IBS-C Drugs Annual Sales by Company (2020-2022)

3.1.2 Global IBS-C Drugs Sales Market Share by Company (2020-2022)

3.2 Global IBS-C Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global IBS-C Drugs Revenue by Company (2020-2022)

3.2.2 Global IBS-C Drugs Revenue Market Share by Company (2020-2022)

3.3 Global IBS-C Drugs Sale Price by Company

3.4 Key Manufacturers IBS-C Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers IBS-C Drugs Product Location Distribution

3.4.2 Players IBS-C Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for IBS-C Drugs by Geographic Region

4.1 World Historic IBS-C Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global IBS-C Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global IBS-C Drugs Annual Revenue by Geographic Region

4.2 World Historic IBS-C Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global IBS-C Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global IBS-C Drugs Annual Revenue by Country/Region

4.3 Americas IBS-C Drugs Sales Growth

4.4 APAC IBS-C Drugs Sales Growth

4.5 Europe IBS-C Drugs Sales Growth

4.6 Middle East & Africa IBS-C Drugs Sales Growth

5 Americas

5.1 Americas IBS-C Drugs Sales by Country

5.1.1 Americas IBS-C Drugs Sales by Country (2017-2022)

5.1.2 Americas IBS-C Drugs Revenue by Country (2017-2022)

5.2 Americas IBS-C Drugs Sales by Type

5.3 Americas IBS-C Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC IBS-C Drugs Sales by Region

6.1.1 APAC IBS-C Drugs Sales by Region (2017-2022)

6.1.2 APAC IBS-C Drugs Revenue by Region (2017-2022)

6.2 APAC IBS-C Drugs Sales by Type

6.3 APAC IBS-C Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe IBS-C Drugs by Country

7.1.1 Europe IBS-C Drugs Sales by Country (2017-2022)

7.1.2 Europe IBS-C Drugs Revenue by Country (2017-2022)

7.2 Europe IBS-C Drugs Sales by Type

7.3 Europe IBS-C Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa IBS-C Drugs by Country

8.1.1 Middle East & Africa IBS-C Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa IBS-C Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa IBS-C Drugs Sales by Type

8.3 Middle East & Africa IBS-C Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of IBS-C Drugs

10.3 Manufacturing Process Analysis of IBS-C Drugs

10.4 Industry Chain Structure of IBS-C Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 IBS-C Drugs Distributors

11.3 IBS-C Drugs Customer

12 World Forecast Review for IBS-C Drugs by Geographic Region

12.1 Global IBS-C Drugs Market Size Forecast by Region

12.1.1 Global IBS-C Drugs Forecast by Region (2023-2028)

12.1.2 Global IBS-C Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global IBS-C Drugs Forecast by Type

12.7 Global IBS-C Drugs Forecast by Application

13 Key Players Analysis

13.1 Catalent Pharmaceuticals Solutions

13.1.1 Catalent Pharmaceuticals Solutions Company Information

13.1.2 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Offered

13.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Catalent Pharmaceuticals Solutions Main Business Overview

13.1.5 Catalent Pharmaceuticals Solutions Latest Developments

13.2 Nestle

13.2.1 Nestle Company Information

13.2.2 Nestle IBS-C Drugs Product Offered

13.2.3 Nestle IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Nestle Main Business Overview

13.2.5 Nestle Latest Developments

13.3 Abbott Laboratories

13.3.1 Abbott Laboratories Company Information

13.3.2 Abbott Laboratories IBS-C Drugs Product Offered

13.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Abbott Laboratories Main Business Overview

13.3.5 Abbott Laboratories Latest Developments

13.4 Synergy Pharmaceuticals

13.4.1 Synergy Pharmaceuticals Company Information

13.4.2 Synergy Pharmaceuticals IBS-C Drugs Product Offered

13.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Synergy Pharmaceuticals Main Business Overview

13.4.5 Synergy Pharmaceuticals Latest Developments

13.5 Sucampo Pharmaceuticals

13.5.1 Sucampo Pharmaceuticals Company Information

13.5.2 Sucampo Pharmaceuticals IBS-C Drugs Product Offered

13.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sucampo Pharmaceuticals Main Business Overview

13.5.5 Sucampo Pharmaceuticals Latest Developments

13.6 Novartis Pharma Ag

13.6.1 Novartis Pharma Ag Company Information

13.6.2 Novartis Pharma Ag IBS-C Drugs Product Offered

13.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Pharma Ag Main Business Overview

13.6.5 Novartis Pharma Ag Latest Developments

13.7 Astellas Pharmaceuticals

13.7.1 Astellas Pharmaceuticals Company Information

13.7.2 Astellas Pharmaceuticals IBS-C Drugs Product Offered

13.7.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Astellas Pharmaceuticals Main Business Overview

13.7.5 Astellas Pharmaceuticals Latest Developments

13.8 Ardelyx, Inc

13.8.1 Ardelyx, Inc Company Information

13.8.2 Ardelyx, Inc IBS-C Drugs Product Offered

13.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ardelyx, Inc Main Business Overview

13.8.5 Ardelyx, Inc Latest Developments

13.9 Synthetic Biologics, Inc

13.9.1 Synthetic Biologics, Inc Company Information

13.9.2 Synthetic Biologics, Inc IBS-C Drugs Product Offered

13.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Synthetic Biologics, Inc Main Business Overview

13.9.5 Synthetic Biologics, Inc Latest Developments

13.10 Teva Pharmaceutical Industries

13.10.1 Teva Pharmaceutical Industries Company Information

13.10.2 Teva Pharmaceutical Industries IBS-C Drugs Product Offered

13.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceutical Industries Main Business Overview

13.10.5 Teva Pharmaceutical Industries Latest Developments

13.11 Bama-Geve, SLU

13.11.1 Bama-Geve, SLU Company Information

13.11.2 Bama-Geve, SLU IBS-C Drugs Product Offered

13.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bama-Geve, SLU Main Business Overview

13.11.5 Bama-Geve, SLU Latest Developments

13.12 Ferring BV

13.12.1 Ferring BV Company Information

13.12.2 Ferring BV IBS-C Drugs Product Offered

13.12.3 Ferring BV IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Ferring BV Main Business Overview

13.12.5 Ferring BV Latest Developments

13.13 Ironwood Pharmaceuticals, Inc

13.13.1 Ironwood Pharmaceuticals, Inc Company Information

13.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Offered

13.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Ironwood Pharmaceuticals, Inc Main Business Overview

13.13.5 Ironwood Pharmaceuticals, Inc Latest Developments

13.14 Salix Pharmaceuticals Ltd

13.14.1 Salix Pharmaceuticals Ltd Company Information

13.14.2 Salix Pharmaceuticals Ltd IBS-C Drugs Product Offered

13.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Salix Pharmaceuticals Ltd Main Business Overview

13.14.5 Salix Pharmaceuticals Ltd Latest Developments

13.15 Norgine B.V

13.15.1 Norgine B.V Company Information

13.15.2 Norgine B.V IBS-C Drugs Product Offered

13.15.3 Norgine B.V IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Norgine B.V Main Business Overview

13.15.5 Norgine B.V Latest Developments

13.16 Prometheus Laboratories Inc

13.16.1 Prometheus Laboratories Inc Company Information

13.16.2 Prometheus Laboratories Inc IBS-C Drugs Product Offered

13.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Prometheus Laboratories Inc Main Business Overview

13.16.5 Prometheus Laboratories Inc Latest Developments

13.17 Actavis Nordic A/S

13.17.1 Actavis Nordic A/S Company Information

13.17.2 Actavis Nordic A/S IBS-C Drugs Product Offered

13.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Actavis Nordic A/S Main Business Overview

13.17.5 Actavis Nordic A/S Latest Developments

13.18 Albireo Pharma Inc

13.18.1 Albireo Pharma Inc Company Information

13.18.2 Albireo Pharma Inc IBS-C Drugs Product Offered

13.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Albireo Pharma Inc Main Business Overview

13.18.5 Albireo Pharma Inc Latest Developments

13.19 Yuhan Corp

13.19.1 Yuhan Corp Company Information

13.19.2 Yuhan Corp IBS-C Drugs Product Offered

13.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Yuhan Corp Main Business Overview

13.19.5 Yuhan Corp Latest Developments

13.20 Astrazeneca Plc

13.20.1 Astrazeneca Plc Company Information

13.20.2 Astrazeneca Plc IBS-C Drugs Product Offered

13.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Astrazeneca Plc Main Business Overview

13.20.5 Astrazeneca Plc Latest Developments

13.21 The Menarini Group

13.21.1 The Menarini Group Company Information

13.21.2 The Menarini Group IBS-C Drugs Product Offered

13.21.3 The Menarini Group IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 The Menarini Group Main Business Overview

13.21.5 The Menarini Group Latest Developments

13.22 Ono Pharmaceutical Co., Ltd

13.22.1 Ono Pharmaceutical Co., Ltd Company Information

13.22.2 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Offered

13.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Ono Pharmaceutical Co., Ltd Main Business Overview

13.22.5 Ono Pharmaceutical Co., Ltd Latest Developments

14 Research Findings and Conclusion

Table 1. IBS-C Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. IBS-C Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Linaclotide

Table 4. Major Players of Lubiprostone

Table 5. Major Players of Osmotic Laxatives

Table 6. Major Players of Stimulant Laxatives

Table 7. Major Players of Others

Table 8. Global IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)

Table 9. Global IBS-C Drugs Sales Market Share by Type (2017-2022)

Table 10. Global IBS-C Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global IBS-C Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global IBS-C Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)

Table 14. Global IBS-C Drugs Sales Market Share by Application (2017-2022)

Table 15. Global IBS-C Drugs Revenue by Application (2017-2022)

Table 16. Global IBS-C Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global IBS-C Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global IBS-C Drugs Sales by Company (2020-2022) & (K Pcs)

Table 19. Global IBS-C Drugs Sales Market Share by Company (2020-2022)

Table 20. Global IBS-C Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global IBS-C Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global IBS-C Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers IBS-C Drugs Producing Area Distribution and Sales Area

Table 24. Players IBS-C Drugs Products Offered

Table 25. IBS-C Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global IBS-C Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global IBS-C Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global IBS-C Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global IBS-C Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global IBS-C Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global IBS-C Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global IBS-C Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global IBS-C Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas IBS-C Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas IBS-C Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas IBS-C Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas IBS-C Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas IBS-C Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC IBS-C Drugs Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC IBS-C Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC IBS-C Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC IBS-C Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC IBS-C Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC IBS-C Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe IBS-C Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe IBS-C Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe IBS-C Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe IBS-C Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe IBS-C Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa IBS-C Drugs Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa IBS-C Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa IBS-C Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa IBS-C Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa IBS-C Drugs Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa IBS-C Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa IBS-C Drugs Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa IBS-C Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of IBS-C Drugs

Table 69. Key Market Challenges & Risks of IBS-C Drugs

Table 70. Key Industry Trends of IBS-C Drugs

Table 71. IBS-C Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. IBS-C Drugs Distributors List

Table 74. IBS-C Drugs Customer List

Table 75. Global IBS-C Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global IBS-C Drugs Sales Market Forecast by Region

Table 77. Global IBS-C Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global IBS-C Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas IBS-C Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas IBS-C Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC IBS-C Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC IBS-C Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe IBS-C Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe IBS-C Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa IBS-C Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa IBS-C Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global IBS-C Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global IBS-C Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global IBS-C Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global IBS-C Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global IBS-C Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global IBS-C Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global IBS-C Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global IBS-C Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Catalent Pharmaceuticals Solutions Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Offered

Table 97. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Catalent Pharmaceuticals Solutions Main Business

Table 99. Catalent Pharmaceuticals Solutions Latest Developments

Table 100. Nestle Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Nestle IBS-C Drugs Product Offered

Table 102. Nestle IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Nestle Main Business

Table 104. Nestle Latest Developments

Table 105. Abbott Laboratories Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Abbott Laboratories IBS-C Drugs Product Offered

Table 107. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Abbott Laboratories Main Business

Table 109. Abbott Laboratories Latest Developments

Table 110. Synergy Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Synergy Pharmaceuticals IBS-C Drugs Product Offered

Table 112. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Synergy Pharmaceuticals Main Business

Table 114. Synergy Pharmaceuticals Latest Developments

Table 115. Sucampo Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Sucampo Pharmaceuticals IBS-C Drugs Product Offered

Table 117. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Sucampo Pharmaceuticals Main Business

Table 119. Sucampo Pharmaceuticals Latest Developments

Table 120. Novartis Pharma Ag Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Novartis Pharma Ag IBS-C Drugs Product Offered

Table 122. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Novartis Pharma Ag Main Business

Table 124. Novartis Pharma Ag Latest Developments

Table 125. Astellas Pharmaceuticals Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Astellas Pharmaceuticals IBS-C Drugs Product Offered

Table 127. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Astellas Pharmaceuticals Main Business

Table 129. Astellas Pharmaceuticals Latest Developments

Table 130. Ardelyx, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Ardelyx, Inc IBS-C Drugs Product Offered

Table 132. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Ardelyx, Inc Main Business

Table 134. Ardelyx, Inc Latest Developments

Table 135. Synthetic Biologics, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Synthetic Biologics, Inc IBS-C Drugs Product Offered

Table 137. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Synthetic Biologics, Inc Main Business

Table 139. Synthetic Biologics, Inc Latest Developments

Table 140. Teva Pharmaceutical Industries Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Teva Pharmaceutical Industries IBS-C Drugs Product Offered

Table 142. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Teva Pharmaceutical Industries Main Business

Table 144. Teva Pharmaceutical Industries Latest Developments

Table 145. Bama-Geve, SLU Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Bama-Geve, SLU IBS-C Drugs Product Offered

Table 147. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Bama-Geve, SLU Main Business

Table 149. Bama-Geve, SLU Latest Developments

Table 150. Ferring BV Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 151. Ferring BV IBS-C Drugs Product Offered

Table 152. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Ferring BV Main Business

Table 154. Ferring BV Latest Developments

Table 155. Ironwood Pharmaceuticals, Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 156. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Offered

Table 157. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Ironwood Pharmaceuticals, Inc Main Business

Table 159. Ironwood Pharmaceuticals, Inc Latest Developments

Table 160. Salix Pharmaceuticals Ltd Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 161. Salix Pharmaceuticals Ltd IBS-C Drugs Product Offered

Table 162. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Salix Pharmaceuticals Ltd Main Business

Table 164. Salix Pharmaceuticals Ltd Latest Developments

Table 165. Norgine B.V Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 166. Norgine B.V IBS-C Drugs Product Offered

Table 167. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Norgine B.V Main Business

Table 169. Norgine B.V Latest Developments

Table 170. Prometheus Laboratories Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 171. Prometheus Laboratories Inc IBS-C Drugs Product Offered

Table 172. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. Prometheus Laboratories Inc Main Business

Table 174. Prometheus Laboratories Inc Latest Developments

Table 175. Actavis Nordic A/S Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 176. Actavis Nordic A/S IBS-C Drugs Product Offered

Table 177. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. Actavis Nordic A/S Main Business

Table 179. Actavis Nordic A/S Latest Developments

Table 180. Albireo Pharma Inc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 181. Albireo Pharma Inc IBS-C Drugs Product Offered

Table 182. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 183. Albireo Pharma Inc Main Business

Table 184. Albireo Pharma Inc Latest Developments

Table 185. Yuhan Corp Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 186. Yuhan Corp IBS-C Drugs Product Offered

Table 187. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 188. Yuhan Corp Main Business

Table 189. Yuhan Corp Latest Developments

Table 190. Astrazeneca Plc Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 191. Astrazeneca Plc IBS-C Drugs Product Offered

Table 192. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 193. Astrazeneca Plc Main Business

Table 194. Astrazeneca Plc Latest Developments

Table 195. The Menarini Group Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 196. The Menarini Group IBS-C Drugs Product Offered

Table 197. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 198. The Menarini Group Main Business

Table 199. The Menarini Group Latest Developments

Table 200. Ono Pharmaceutical Co., Ltd Basic Information, IBS-C Drugs Manufacturing Base, Sales Area and Its Competitors

Table 201. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Offered

Table 202. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 203. Ono Pharmaceutical Co., Ltd Main Business

Table 204. Ono Pharmaceutical Co., Ltd Latest Developments

List of Figures

Figure 1. Picture of IBS-C Drugs

Figure 2. IBS-C Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global IBS-C Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global IBS-C Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. IBS-C Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Linaclotide

Figure 10. Product Picture of Lubiprostone

Figure 11. Product Picture of Osmotic Laxatives

Figure 12. Product Picture of Stimulant Laxatives

Figure 13. Product Picture of Others

Figure 14. Global IBS-C Drugs Sales Market Share by Type in 2021

Figure 15. Global IBS-C Drugs Revenue Market Share by Type (2017-2022)

Figure 16. IBS-C Drugs Consumed in Hospital Pharmacies

Figure 17. Global IBS-C Drugs Market: Hospital Pharmacies (2017-2022) & (K Pcs)

Figure 18. IBS-C Drugs Consumed in Retail Pharmacies

Figure 19. Global IBS-C Drugs Market: Retail Pharmacies (2017-2022) & (K Pcs)

Figure 20. IBS-C Drugs Consumed in Online Pharmacies

Figure 21. Global IBS-C Drugs Market: Online Pharmacies (2017-2022) & (K Pcs)

Figure 22. Global IBS-C Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global IBS-C Drugs Revenue Market Share by Application in 2021

Figure 24. IBS-C Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global IBS-C Drugs Revenue Market Share by Company in 2021

Figure 26. Global IBS-C Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global IBS-C Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global IBS-C Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global IBS-C Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas IBS-C Drugs Sales 2017-2022 (K Pcs)

Figure 31. Americas IBS-C Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC IBS-C Drugs Sales 2017-2022 (K Pcs)

Figure 33. APAC IBS-C Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe IBS-C Drugs Sales 2017-2022 (K Pcs)

Figure 35. Europe IBS-C Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa IBS-C Drugs Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa IBS-C Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas IBS-C Drugs Sales Market Share by Country in 2021

Figure 39. Americas IBS-C Drugs Revenue Market Share by Country in 2021

Figure 40. United States IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC IBS-C Drugs Sales Market Share by Region in 2021

Figure 45. APAC IBS-C Drugs Revenue Market Share by Regions in 2021

Figure 46. China IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe IBS-C Drugs Sales Market Share by Country in 2021

Figure 53. Europe IBS-C Drugs Revenue Market Share by Country in 2021

Figure 54. Germany IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa IBS-C Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa IBS-C Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country IBS-C Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of IBS-C Drugs in 2021

Figure 67. Manufacturing Process Analysis of IBS-C Drugs

Figure 68. Industry Chain Structure of IBS-C Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles